CYP chart, page-454

Sector, nice short term trade. After 4 major deals in the stem cell space this year not game enough to sell any, have actually bought more. I'm to concerned that they move to a trading halt and open at $3 $4 $5 bid if CYP management can secure a deal like any of the 4 done this year in my opinion.
Of all my bio techs this one I see as potentially massive. I agree with Philby that this technology is ground breaking and in my opinion could lead to multiple deals and a price much much higher, hard to put a figure on it without sounding ridiculous.
Bluntly, in my opinion I wouldn't be underweight CYP over the next 6 to 7 months